Ozempic, a popular GLP-1 receptor agonist for type 2 diabetes and weight loss, has seen a surge in prescriptions, with over 9 million Americans reportedly using the medication in 2023 (source). Despite its effectiveness, Ozempic can affect multiple organ systems, making side effect monitoring complex. Many adverse reactions are detected late or under-reported due to subtle onset and lack of awareness among patients and providers. This article explores the lesser-known side effects and the challenges associated with recognizing them early.
Health
Disclaimer The information provided in this article is for general informational purposes only. While we strive to keep the information up-to-date and correct, we make no…